Ultragenyx Pharmaceutical, Inc. (RARE)
24.17
+0.77
(+3.29%)
USD |
NASDAQ |
Jan 23, 12:45
Ultragenyx Pharmaceutical Research and Development Expense (TTM): 699.19M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 260.35M |
| Johnson & Johnson | 14.70B |
| CorMedix, Inc. | 12.46M |
| Amicus Therapeutics, Inc. | 142.29M |
| Geron Corp. | 81.32M |